S. Muoio & CO. LLC Has $615,000 Holdings in Phibro Animal Health Corp (PAHC)
S. Muoio & CO. LLC lessened its stake in Phibro Animal Health Corp (NASDAQ:PAHC) by 44.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,336 shares of the company’s stock after selling 11,610 shares during the period. S. Muoio & CO. LLC’s holdings in Phibro Animal Health were worth $615,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in Phibro Animal Health by 7.7% in the second quarter. BlackRock Inc. now owns 3,304,441 shares of the company’s stock worth $152,169,000 after acquiring an additional 235,932 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Phibro Animal Health by 18.2% in the second quarter. Renaissance Technologies LLC now owns 634,500 shares of the company’s stock worth $29,219,000 after acquiring an additional 97,700 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Phibro Animal Health by 4.1% in the second quarter. Dimensional Fund Advisors LP now owns 502,525 shares of the company’s stock worth $23,141,000 after acquiring an additional 19,807 shares in the last quarter. Segall Bryant & Hamill LLC acquired a new stake in Phibro Animal Health in the second quarter worth about $21,724,000. Finally, Northern Trust Corp boosted its holdings in Phibro Animal Health by 10.2% in the second quarter. Northern Trust Corp now owns 408,290 shares of the company’s stock worth $18,802,000 after acquiring an additional 37,946 shares in the last quarter. Institutional investors own 48.25% of the company’s stock.
Shares of NASDAQ PAHC opened at $36.05 on Thursday. The company has a debt-to-equity ratio of 1.62, a current ratio of 3.26 and a quick ratio of 1.82. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of 20.72, a price-to-earnings-growth ratio of 3.02 and a beta of 0.82. Phibro Animal Health Corp has a fifty-two week low of $32.05 and a fifty-two week high of $54.62.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Wednesday, November 28th will be issued a dividend of $0.12 per share. This is an increase from Phibro Animal Health’s previous quarterly dividend of $0.10. The ex-dividend date is Tuesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.33%. Phibro Animal Health’s payout ratio is 22.99%.
In related news, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $42.84, for a total transaction of $428,400.00. Following the completion of the sale, the insider now owns 10,000 shares of the company’s stock, valued at $428,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Daniel M. Bendheim sold 2,500 shares of Phibro Animal Health stock in a transaction dated Wednesday, September 12th. The stock was sold at an average price of $44.30, for a total value of $110,750.00. Following the sale, the vice president now directly owns 2,500 shares of the company’s stock, valued at approximately $110,750. The disclosure for this sale can be found here. Insiders have sold 93,020 shares of company stock valued at $4,481,471 in the last ninety days. Corporate insiders own 50.29% of the company’s stock.
Several brokerages have weighed in on PAHC. BidaskClub raised Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Wednesday, August 8th. Zacks Investment Research raised Phibro Animal Health from a “sell” rating to a “buy” rating and set a $53.00 price target for the company in a report on Thursday, August 30th. ValuEngine downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Monday. Finally, Morgan Stanley raised their price target on Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a report on Wednesday, August 29th. Four equities research analysts have rated the stock with a sell rating and two have given a hold rating to the company. The stock has a consensus rating of “Sell” and a consensus price target of $43.50.
WARNING: “S. Muoio & CO. LLC Has $615,000 Holdings in Phibro Animal Health Corp (PAHC)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/11/15/s-muoio-co-llc-has-615000-holdings-in-phibro-animal-health-corp-pahc.html.
Phibro Animal Health Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Featured Article: Marijuana Stocks Future Looks Bright
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.